📦 NDC / package directory — not a drug information page
Elexacaftor, Tezacaftor, And Ivacaftor NDCs, Package Codes, Strengths & Labelers
This page lists NDC package records for Elexacaftor, Tezacaftor, And Ivacaftor products — strengths, dosage forms, package sizes, labelers, 11-digit billing NDCs, pricing data when available, and links to each individual NDC page. It’s an NDC/package & billing directory, not a clinical drug page.
Looking for uses, warnings & side effects? Read our Elexacaftor, Tezacaftor, And Ivacaftor drug information page →Key stats
6
Package NDCs
10
Products
10
Active listings
0
Discontinued
2
Labelers
2
Strengths
2
Dosage forms
0
With NADAC pricing
By strength, form & labeler
NDC products by strength
By dosage form
Top labelers
Browse records — 10 products
| Drug / product | Billing NDC | NADAC / unit | Status | |
|---|---|---|---|---|
| elexacaftor, tezacaftor, and ivacaftor 25 mg/1; 50 mg/1; 37.5 mg/1 TABLET, FILM COATED | 67651-0404-00 | — | On market | View → |
| elexacaftor, tezacaftor, and ivacaftor 50 mg/1; 100 mg/1; 75 mg/1 TABLET, FILM COATED | 67651-0405-00 | — | On market | View → |
| Trikafta Elexacaftor, Tezacaftor, and Ivacaftor KIT | 51167-0445-01 | — | On market | View → |
| Trikafta Elexacaftor, Tezacaftor, and Ivacaftor KIT | 51167-0106-02 | — | On market | View → |
| Trikafta Elexacaftor, Tezacaftor, and Ivacaftor KIT | 51167-0331-01 | — | On market | View → |
| Trikafta Elexacaftor, Tezacaftor, and Ivacaftor KIT | 51167-0446-01 | — | On market | View → |
| Trikafta Elexacaftor, Tezacaftor, and Ivacaftor KIT | 51167-0445-01 | — | On market | View → |
| Trikafta Elexacaftor, Tezacaftor, and Ivacaftor KIT | 51167-0106-02 | — | On market | View → |
| Trikafta Elexacaftor, Tezacaftor, and Ivacaftor KIT | 51167-0446-01 | — | On market | View → |
| Trikafta Elexacaftor, Tezacaftor, and Ivacaftor KIT | 51167-0331-01 | — | On market | View → |
Where does this data come from?
NDC package records, strengths, forms and labelers come from the openFDA NDC Directory; pricing is CMS NADAC. Grouped by active-ingredient name. This is package/billing reference data, not clinical drug information.